Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease by Yuqi Qiu, Diane M. Jacobs, Karen Messer, David P. Salmon, Cheryl L. Wellington, Sophie Stukas, Carolyn Revta, James B. Brewer, Gabriel C. Léger, Brianna Askew, Lia Donahue, Stephen Kaplita, Vladimir Coric, Irfan A. Qureshi, Howard H. Feldman, The Alzheimer’s Disease Cooperative Study T2 Protect AD Study Group

Get full text

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's di... by Howard H Feldman, José A Luchsinger, Gabriel C Léger, Curtis Taylor, Diane M Jacobs, David P Salmon, Steven D Edland, Karen Messer, Carolyn Revta, Sarah A Flowers, Kerry S Jones, Albert Koulman, Kevin E Yarasheski, Philip B Verghese, Venky Venkatesh, Henrik Zetterberg, January Durant, Jody-Lynn Lupo, Gary E Gibson, ADCS BenfoTeam Study Group

Get full text

Protocol for SYNchronising Exercises, Remedies in GaIt and Cognition at Home (SYNERGIC@Home): feasibility of a home-based double-blind randomised controlled trial to improve gait a... by Teresa Liu-Ambrose, Eric Smith, Karen Messer, Pam Jarrett, Jennifer Walker, Louis Bherer, Andrew Lim, Nicole Anderson, Quincy J Almeida, Howard Feldman, Howard Chertkow, Nellie Kamkar, Manuel Montero-Odasso, Mark Speechley, Chris McGibbon, Grant Handrigan, Danielle Bouchard, Andrew M Sexton, Linda Yetman, Bryn Robinson, Stephanie Crapoulet, Ludivine Chamard-Witkowski, Laura Elizabeth Middleton, Manuel Montero Odasso, Sylvie Belleville, Haakon Nygaard, Danielle Alcock, Sarah Banks, Paul Brewster, Senny Chan, Marc Cuesta, Samir Das, Carol Evans, Guylaine Ferland, Tati Herold, Scott Hofer, Inbal Itzhak, Diane Jacobs, Jody-Lynn Lupo, Lisa Madlensky, Zia Mohades, Carolyn Revta, Julie Robillard, Penny Slack, Jingjing Zou, Carole C Tranchant

Get full text